Stanley Westreich - Net Worth and Insider Trading

Stanley Westreich Net Worth

The estimated net worth of Stanley Westreich is at least $16 Million dollars as of 2024-04-26. Stanley Westreich is the Director of Capital One Financial Corp and owns about 105,343 shares of Capital One Financial Corp (COF) stock worth over $16 Million. Details can be seen in Stanley Westreich's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stanley Westreich has not made any transactions after 2009-07-31 and currently still holds the listed stock(s).

Transaction Summary of Stanley Westreich

To

Stanley Westreich Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stanley Westreich owns 3 companies in total, including Seneca Biopharma Inc (SNCA) , Capital One Financial Corp (COF) , and Palisade Bio Inc (PALI) .

Click here to see the complete history of Stanley Westreich’s form 4 insider trades.

Insider Ownership Summary of Stanley Westreich

Ticker Comapny Transaction Date Type of Owner
SNCA Seneca Biopharma Inc 2018-07-02 director
COF Capital One Financial Corp 2009-07-31 director
PALI Palisade Bio Inc 2006-08-30 10 percent owner

Stanley Westreich Latest Holdings Summary

Stanley Westreich currently owns a total of 1 stock. Stanley Westreich owns 105,343 shares of Capital One Financial Corp (COF) as of July 31, 2009, with a value of $16 Million.

Latest Holdings of Stanley Westreich

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
COF Capital One Financial Corp 2009-07-31 105,343 148.10 15,601,298

Holding Weightings of Stanley Westreich


Stanley Westreich Form 4 Trading Tracker

According to the SEC Form 4 filings, Stanley Westreich has made a total of 0 transactions in Capital One Financial Corp (COF) over the past 5 years. The most-recent trade in Capital One Financial Corp is the sale of 50,000 shares on July 31, 2009, which brought Stanley Westreich around $2 Million.

Insider Trading History of Stanley Westreich

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stanley Westreich Trading Performance

GuruFocus tracks the stock performance after each of Stanley Westreich's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stanley Westreich is -3.04%. GuruFocus also compares Stanley Westreich's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stanley Westreich within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Stanley Westreich's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Stanley Westreich

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -4.02 -3.04 2.18 -13.84 -8.97 -18.83
Relative Return to S&P 500(%) -4.58 -3.09 -0.49 -16.48 -17.52 -20.51

Stanley Westreich Ownership Network

Ownership Network List of Stanley Westreich

No Data

Ownership Network Relation of Stanley Westreich


Stanley Westreich Owned Company Details

What does Seneca Biopharma Inc do?

Who are the key executives at Seneca Biopharma Inc?

Stanley Westreich is the director of Seneca Biopharma Inc. Other key executives at Seneca Biopharma Inc include director & Executive Chairman Kenneth C Carter , director & Chief Executive Officer Richard J Daly , and Chief Financial Officer Lloyd Jones Jonathan Brian .

Seneca Biopharma Inc (SNCA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Seneca Biopharma Inc (SNCA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Seneca Biopharma Inc (SNCA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Seneca Biopharma Inc (SNCA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Seneca Biopharma Inc Insider Transactions

No Available Data

Stanley Westreich Mailing Address

Above is the net worth, insider trading, and ownership report for Stanley Westreich. You might contact Stanley Westreich via mailing address: 1680 Capital One Drive, Mclean Va 22102.

Discussions on Stanley Westreich

No discussions yet.